Search results
Author(s):
Mads Brix Kronborg
Added:
7 months ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158).
DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40…
View more
Added:
1 month ago
Source:
EHRA 2024
The European Heart Rhythm Association (EHRA) Congress has announced four late-breaking clinical trial sessions to be presented in April.EHRA 24 will take place in Berlin and online from the 7th to the 9th April 2024. Access the full programme here.Late-Breaking Science: ClinicalSunday 7th April, 13:45 – 14:45 Central European TimeArtificial intelligence-enabled single-lead ambulatory ECG can…
View more
Author(s):
Richard Sutton
Added:
3 years ago
Syncope in a patient with a pacemaker commands urgent action to ascertain its cause and provide appropriate treatment. This is a well accepted statement but the field has evolved in recent years and, strangely, has received little attention.
Many considerations bear on this issue. First, syncope in pacemaker patients is not common but may be more so than generally considered. The lack of…
View more
Author(s):
Moinuddin Choudhury
,
Mark R Boyett
,
Gwilym M Morris
Added:
3 years ago
The sinoatrial or sinus node (SAN) is the heart’s natural pacemaker. Located in the superior right atrium, it automatically produces cyclical electrical activity to initiate each heartbeat in normal sinus rhythm. SAN dysfunction (SND) in humans, also known as ‘sick sinus syndrome’, can manifest as pathological bradycardia and asystolic pauses. As a result, SND can lead to symptoms of reduced…
View more
Author(s):
Yugo Yamashita
Added:
7 months ago
What's hot at the European Society of Cardiology (ESC) Congress 2023?
Browse our curated coverage of the latest updates in cardiology from Amsterdam.
Watch ourView From the Thoraxcenterseries for a concise line up of the most awaited trials fromProf Nicolas Van MieghemandDr Joost Daemen.
For a deeper dive into key clinical trial data and its applicability, host,Dr Harriette Van…
View more
Author(s):
Dario DiFrancesco
Added:
3 years ago
HCN4 (hyperpolarisation-activated, cyclic nucleotide gated 4) channels, the pore-forming α–subunits of ‘funny’ channels originally described in pacemaker cells of the sinoatrial node (SAN),1 are responsible for the early phase of diastolic depolarisation in these cells and are key determinants of pacemaker generation and control of heart rate.2–5 HCN4 channels are selectively expressed in the SAN…
View more
Author(s):
Wei-Yao Lim
,
Sandeep Prabhu
Added:
3 years ago
The number of cardiac implantable electronic devices (CIED) has been increasing year-on-year.1 This, coupled with improvements in life expectancy,2 means that more elderly patients will meet the criteria for a CIED. National and international guidelines set out clear criteria and make recommendations for CIED use based on available evidence.3–6 However, the majority of clinical trials include few…
View more
Author(s):
Saad Fyyaz
,
Michael Papadakis
Added:
1 year ago
Author(s):
Melani Sotiriadou
,
Antonios P Antoniadis
,
Nikolaos Fragakis
,
et al
Added:
2 years ago
Author(s):
Ghanshyam Shantha
,
Frank Pelosi
,
Fred Morady
Added:
3 years ago
Prevalence of AF and Obstructive Sleep Apnoea
Nonvalvular AF is the most common sustained arrhythmia, affecting nearly 3 million adult Americans.1–4 By 2050, nearly 12–15 million adults in the US will have AF.1 The global prevalence of obstructive sleep apnoea (OSA) is also increasing. OSA is the most common form of sleep-disordered breathing, affecting 10–15% of the general population (6–9% in…
View more